Mirum Pharmaceuticals, Inc. Current Ratio in % from Q1 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Mirum Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2020 to Q3 2025.
  • Mirum Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2025 was 320 %, a 12.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Mirum Pharmaceuticals, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 320 -44.1 -12.1% Sep 30, 2025
Q2 2025 319 -84.2 -20.9% Jun 30, 2025
Q1 2025 323 -152 -32% Mar 31, 2025
Q4 2024 334 -162 -32.7% Dec 31, 2024
Q3 2024 364 -96.7 -21% Sep 30, 2024
Q2 2024 404 -27.3 -6.34% Jun 30, 2024
Q1 2024 475 +130 +37.7% Mar 31, 2024
Q4 2023 496 +134 +37% Dec 31, 2023
Q3 2023 460 +66.3 +16.8% Sep 30, 2023
Q2 2023 431 +45.3 +11.8% Jun 30, 2023
Q1 2023 345 -132 -27.7% Mar 31, 2023
Q4 2022 362 -154 -29.8% Dec 31, 2022
Q3 2022 394 -268 -40.4% Sep 30, 2022
Q2 2022 386 -424 -52.4% Jun 30, 2022
Q1 2022 477 -361 -43% Mar 31, 2022
Q4 2021 516 -507 -49.6% Dec 31, 2021
Q3 2021 662 -261 -28.3% Sep 30, 2021
Q2 2021 810 -231 -22.2% Jun 30, 2021
Q1 2021 838 -182 -17.8% Mar 31, 2021
Q4 2020 1.02K Dec 31, 2020
Q3 2020 923 Sep 30, 2020
Q2 2020 1.04K Jun 30, 2020
Q1 2020 1.02K Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.